PRESS RELEASE published on 08/21/2024 at 18:00, 2 months 30 days ago Modification des droits attachés aux catégories d'actions Déclaration du nombre total de droits de vote et d'actions composant le capital social de la société anonyme Société Anonyme Droits De Vote Capital Social Actions Règlement Général
BRIEF published on 07/09/2024 at 07:05, 4 months 12 days ago CARMAT dynamise ses ventes et affirme son développement Développement Commercial CARMAT Aeson® Implantations Étude EFICAS
BRIEF published on 07/09/2024 at 07:05, 4 months 12 days ago CARMAT boosts its sales and affirms its development Business Development CARMAT Aeson® Locations EFICAS Study
PRESS RELEASE published on 07/09/2024 at 07:00, 4 months 12 days ago Informations privilégiées / Autres communiqués CARMAT accélère ses ventes avec 20 implantations du cœur artificiel Aeson® réalisées au premier semestre 2024, dépassant le CA annuel 2023. Confiance renouvelée dans ses perspectives de développement Développement Commercial CARMAT Aeson® Étude EFICAS Dynamique Des Ventes
PRESS RELEASE published on 07/09/2024 at 07:00, 4 months 12 days ago Inside Information / Other news releases CARMAT exceeds 2023 sales, with €3.2M revenue in H1 2024 & 20 Aeson® heart implants. Confidence in growth outlook maintained. EFICAS study progressing well Financial Results Sales Momentum CARMAT EFICAS Study Aeson Heart Implants
BRIEF published on 07/08/2024 at 07:05, 4 months 13 days ago CARMAT fera son point semestriel le 9 juillet 2024 Mise À Jour Financière Coeur Artificiel TAPIS DE VOITURE Conférence Vidéo
BRIEF published on 07/08/2024 at 07:05, 4 months 13 days ago CARMAT to Provide Half-Year Update on July 9, 2024 Financial Update CARMAT Artificial Heart Videoconference
PRESS RELEASE published on 07/08/2024 at 07:00, 4 months 13 days ago Inside Information / Other news releases CARMAT to provide a half-year update and host a videoconference in French on July 9, 2024. The update will cover advancements of the Aeson artificial heart and key company developments CARMAT Aeson Artificial Heart Videoconference Half-year Update Therapeutic Alternative
BRIEF published on 06/25/2024 at 07:05, 4 months 26 days ago New governance at CARMAT Governance Nomination Heart Failure CARMAT Pierre Bastid
BRIEF published on 06/25/2024 at 07:05, 4 months 26 days ago Nouvelle gouvernance chez CARMAT Gouvernance Nomination CARMAT Insuffisance Cardiaque Pierre Bastid
Published on 11/21/2024 at 12:00, 50 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 50 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 20 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 47 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 50 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:35, 15 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 35 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 20 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 43 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
